52 related articles for article (PubMed ID: 1407904)
1. Nafarelin versus leuprolide in ovulation induction for in vitro fertilization: a randomized clinical trial.
Lydic ML; Jacobs SL
Obstet Gynecol; 1992 Oct; 80(4):727-9. PubMed ID: 1407904
[No Abstract] [Full Text] [Related]
2. Nafarelin versus leuprolide in ovulation induction for in vitro fertilization: a randomized clinical trial.
Penzias AS; Shamma FN; Gutmann JN; Jones EE; DeCherney AH; Lavy G
Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):739-42. PubMed ID: 1533022
[TBL] [Abstract][Full Text] [Related]
3. The choice of a gonadotropin-releasing hormone analog influences outcome of in vitro fertilization treatment.
Martin MC; Givens CR; Schriock ED; Glass RH; Dandekar PV
Am J Obstet Gynecol; 1994 Jun; 170(6):1629-32; discussion 1632-4. PubMed ID: 8203419
[TBL] [Abstract][Full Text] [Related]
4. Nafarelin acetate for pituitary suppressions in in-vitro fertilisation cycles--a Singaporean experience.
Loh SK; Leong NK
Singapore Med J; 1999 Dec; 40(12):752-5. PubMed ID: 10709427
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin releasing hormone agonists and the induction or augmentation of ovulation.
Martin MC
J Reprod Med; 1989 Dec; 34(12 Suppl):1034-8. PubMed ID: 2533619
[TBL] [Abstract][Full Text] [Related]
6. Impact of nafarelin and leuprolide for endometriosis on quality of life and subjective clinical measures.
Zhao SZ; Kellerman LA; Francisco CA; Wong JM
J Reprod Med; 1999 Dec; 44(12):1000-6. PubMed ID: 10649809
[TBL] [Abstract][Full Text] [Related]
7. Leuprolide acetate for inducing ovulation in women undergoing ovarian stimulation.
diDonato P; Nola VF; Pittman TV; Marr V; Stubbs C; Meldrum DR
J Reprod Med; 1995 Oct; 40(10):715-6. PubMed ID: 8551474
[TBL] [Abstract][Full Text] [Related]
8. [Revisiting GnRH analog protocols II. Strategy for poor responders].
Hugues JN; Cédrin-Durnerin I
Contracept Fertil Sex; 1997 Sep; 25(9):717-24. PubMed ID: 9410395
[TBL] [Abstract][Full Text] [Related]
9. Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group.
Agarwal SK; Hamrang C; Henzl MR; Judd HL
J Reprod Med; 1997 Jul; 42(7):413-23. PubMed ID: 9252932
[TBL] [Abstract][Full Text] [Related]
10. Cost comparisons between nafarelin and leuprolide in the treatment of endometriosis.
Zhao SZ; Arguelles LM; Wong JM; Davis MB; Gersh GE; Struthers BJ
Clin Ther; 1998; 20(3):592-602. PubMed ID: 9663373
[TBL] [Abstract][Full Text] [Related]
11. Nafarelin acetate for pituitary down-regulation in in vitro fertilization. Comparison of two dosages.
Yuzpe AA; Nisker JA; Kaplan BR; Tummon IS; Auckland J
J Reprod Med; 1995 Feb; 40(2):83-8. PubMed ID: 7738933
[TBL] [Abstract][Full Text] [Related]
12. Opposite responses to the addition of leuprolide acetate to human menopausal gonadotropin therapy in two perimenopausal women.
Check JH; Adelson HG
Int J Fertil; 1990; 35(6):343-6. PubMed ID: 1981209
[TBL] [Abstract][Full Text] [Related]
13. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer.
Cottreau CM; Ness RB; Modugno F; Allen GO; Goodman MT
Clin Cancer Res; 2003 Nov; 9(14):5142-4. PubMed ID: 14613992
[TBL] [Abstract][Full Text] [Related]
14. A double-blind comparison of nafarelin and leuprolide acetate for down-regulation in IVF cycles.
Corson SL; Gutmann JN; Batzer FR; Gocial B
Int J Fertil Menopausal Stud; 1996; 41(5):446-9. PubMed ID: 8934250
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value assessment of the early response of blood estradiol, FSH, and LH using leuprolide acetate during ovarian hyperstimulation in assisted reproduction].
Sondón García Z; Alvarado A; Peraza Briones C; González Sánchez R; Jiménez Perea L
Ginecol Obstet Mex; 2001 Feb; 69():65-71. PubMed ID: 11339176
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
17. [Ovulation induction in women in the in vitro fertilization program].
Vuleta D; Begenisić M
Med Pregl; 1996; 49(11-12):497-500. PubMed ID: 9019636
[TBL] [Abstract][Full Text] [Related]
18. [Is there a role for GnRH analogs in ovulation stimulation for in vitro fertilization?].
Belaisch-Allart J; Mayenga JM
Contracept Fertil Sex; 1998 Nov; 26(11):761-3. PubMed ID: 9864882
[No Abstract] [Full Text] [Related]
19. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone during ovulation induction for in-vitro fertilization: a pilot study.
Rein MS; Jackson KV; Sable DB; Thomas PP; Hornstein MD
Hum Reprod; 1996 Feb; 11(2):253-5. PubMed ID: 8964890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
